University Of Rome Tor Vergata

This study aims to learn if a PET scan taken six weeks after starting immunotherapy can predict how well the treatment will work months later for people with advanced head and neck cancer. Researchers will observe 25 patients receiving standard pembrolizumab treatment and track t…